Discovery of LB30057, a benzamidrazone-based selective oral thrombin inhibitor
Yeong Soo Oh(STR Biotech (South Korea)), Sang Soo Kim(Georgetown University), Koo Lee(Biotechnology Research Institute), Kyung Hee Yoon(Biotechnology Research Institute), Chang Ho Lee(Soonchunhyang University), Mikyung Yun(The Catholic University of Korea Bucheon St. Mary's Hospital), Sun Hwa Lee(Samsung Medical Center), Yung Joon Yoo(Gwangju Institute of Science and Technology), Sang Koo Lee(Biotechnology Research Institute), Yong Hee Lee(Biotechnology Research Institute), Sang Yeul Hwang(Biotechnology Research Institute), Seongwon Hong(Biotechnology Research Institute), Youseung Shin(Biotechnology Research Institute), Dong Soo Kim(Incheon St. Mary's Hospital), Hee Dong Park(Biotechnology Research Institute)
Cited by 41
Related Papers
A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases
|Journal of Ginseng Research|2014|426
FLIP-mediated autophagy regulation in cell death control
|Nature Cell Biology|2009|398
NSAID Activated Gene (NAG-1), a Modulator of Tumorigenesis
|BMB Reports|2006|123
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
|Nucleic Acids Research|2017|123